Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,243.00
Bid: 4,243.00
Ask: 4,244.00
Change: 14.00 (0.33%)
Spread: 1.00 (0.024%)
Open: 4,231.00
High: 4,248.00
Low: 4,228.00
Prev. Close: 4,229.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Director Remuneration Report AGM Vote

30 Oct 2023 16:33

RNS Number : 7569R
Unilever PLC
30 October 2023
 

Unilever PLC

Statement detailing outcome of shareholder engagement following Directors' Remuneration Report (DRR) vote at the Annual General Meeting (AGM) on 3 May 2023

 

At the 2023 AGM, the resolution to receive and adopt the Directors' Remuneration Report (Resolution 2) was not passed, with a minority of 42% of votes cast in favour of the resolution. 

 

Following the AGM, the Company has undertaken an extensive engagement exercise with shareholders to discuss this voting outcome. During this period, we contacted 28 of our largest shareholders representing around 40% of the shares on our shareholder register, inviting them to meet. 24 shareholders accepted this invitation and we conducted a total of 37 meetings during the engagement exercise.

 

The feedback received from this process informed us that the primary reason for the limited support for the DRR was the approach taken to setting the incoming CEO's remuneration on appointment. Specifically, whilst the majority of shareholders agreed that the fixed pay level for the new CEO appropriately reflected the size and complexity of the role, there was a preference that alignment with the market could have been achieved gradually, rather than in one step on appointment.

 

The Compensation Committee considered this feedback carefully and the Board has decided to freeze the CEO's fixed pay for the next two years. Therefore, he will not be eligible for a fixed pay increase in 2024 or 2025, with the Compensation Committee next reviewing his fixed pay level in 2026. This approach of restricting any increases over the first years of appointment is intended to reflect and align with shareholder views in the engagement process that market alignment should be achieved in 2-3 years following appointment.

 

Discussions with shareholders were not limited to the response to the vote. We have also started discussions with shareholders on the renewal of our Remuneration Policy in 2024 and its implementation. The feedback received to date has been valuable and will help to shape our final proposals. We will engage further with shareholders on the Remuneration Policy as required ahead of the Committee finalising the proposed approach which will be published in the remuneration report early next year.

 

We would like to thank all the shareholders who spent time spent engaging with us. The perspectives of our major shareholders are a critical input into the Committee's deliberations, and we continue to be committed to ongoing and open dialogue, including as we consider our 2024 Remuneration Policy.

 

Unilever PLC is publishing this statement as required by the UK Corporate Governance Code in response to the votes received against the DRR resolution at our AGM on 3 May 2023.

 

Andrea Jung

Chair of the Compensation Committee

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRNKKBNABDDBKN
Date   Source Headline
24th Mar 20234:30 pmRNSTransaction in Own Shares
24th Mar 20234:21 pmRNSTransaction in Own Shares
24th Mar 20232:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20235:00 pmRNSTransaction in Own Shares
23rd Mar 202311:47 amRNSDirector/PDMR Shareholding
22nd Mar 20235:06 pmRNSTransaction in Own Shares
21st Mar 20234:52 pmRNSTransaction in Own Shares
20th Mar 20234:54 pmRNSTransaction in Own Shares
20th Mar 20232:59 pmRNSNotice of AGM
17th Mar 20235:06 pmRNSTransaction in Own Shares
17th Mar 20234:31 pmRNSDirector/PDMR Shareholding
17th Mar 20237:45 amRNSShare Buy-Back Programme
14th Mar 20234:06 pmRNSDirector/PDMR Shareholding
13th Mar 20236:20 pmRNSAnnual Report on Form 20-F
10th Mar 20235:47 pmRNSDirector/PDMR Shareholding
9th Mar 20236:22 pmRNSAnnual Financial Report
3rd Mar 202310:49 amRNSTotal Voting Rights
2nd Mar 20239:19 amRNSDirectorate Change
17th Feb 20234:38 pmRNSDirector/PDMR Shareholding
14th Feb 20235:51 pmRNSDirector/PDMR Shareholding
10th Feb 20236:03 pmRNSDirector/PDMR Shareholding
10th Feb 20234:49 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSFinal Results
2nd Feb 20231:22 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSDirectorate Change
13th Jan 202312:06 pmRNSPDMR Shareholding
4th Jan 202312:59 pmRNSTotal Voting Rights
20th Dec 20223:07 pmRNSPDMR Shareholding
19th Dec 20225:48 pmRNSDirector/PDMR Shareholding
19th Dec 20225:45 pmRNSShare Buyback Programme
19th Dec 20225:38 pmRNSTransaction in Own Shares
16th Dec 20226:05 pmRNSTransaction in Own Shares
15th Dec 20226:07 pmRNSTransaction in Own Shares
15th Dec 20225:35 pmRNSDirector/PDMR Shareholding
15th Dec 20223:04 pmRNSBlock listing of Shares
14th Dec 20226:12 pmRNSTransaction in Own Shares
13th Dec 20226:02 pmRNSTransaction in Own Shares
13th Dec 20223:59 pmRNSDirector/PDMR Shareholding
13th Dec 20222:40 pmRNSDirector/PDMR Shareholding
12th Dec 20225:51 pmRNSTransaction in Own Shares
12th Dec 202212:47 pmRNSDirector/PDMR Shareholding
9th Dec 20225:28 pmRNSTransaction in Own Shares
8th Dec 20226:14 pmRNSTransaction in Own Shares
7th Dec 20226:05 pmRNSTransaction in Own Shares
7th Dec 20224:54 pmRNSCapital Markets Day
6th Dec 20226:01 pmRNSTransaction in Own Shares
5th Dec 20225:53 pmRNSTransaction in Own Shares
2nd Dec 20226:10 pmRNSTransaction in Own Shares
2nd Dec 20225:38 pmRNSDirector/PDMR Shareholding - Replacement
1st Dec 20225:43 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.